N6‐methyladenosine demethyltransferase FTO alleviates sepsis by upregulating BNIP3 to induce mitophagy
N6-methyladenosine (m6A) is known to be crucial in various biological processes, but its role in sepsis-induced circulatory and cardiac dysfunction is not well understood. Specifically, mitophagy, a specialized form of autophagy, is excessively activated during lipopolysaccharide (LPS)-induced myocardial injury. This study aimed to investigate the impact of LPS-induced endotoxemia on m6A-RNA methylation and its role in regulating mitophagy in sepsis-induced myocardial dysfunction. Our research demonstrated that FTO (fat mass and obesity-associated protein), an m6A demethylase, significantly affects abnormal m6A modification in the myocardium and cardiomyocytes following LPS treatment. In mice, cardiac dysfunction and cardiomyocyte apoptosis worsened after adeno-associated virus serotype 9 (AAV9)-mediated FTO knockdown. Further analyses to uncover the cellular mechanisms improving cardiac function showed that FTO reduced mitochondrial reactive oxygen species, restored both basal and maximal respiration, and preserved mitochondrial membrane potential. We revealed that FTO plays a critical role in activating mitophagy by targeting BNIP3. Additionally, the cardioprotective effects of AAV-FTO were significantly compromised by mdivi-1, a mitophagy inhibitor. Mechanistically, FTO interacted with BNIP3 transcripts and regulated their expression in an m6A-dependent manner. Following FTO silencing, BNIP3 transcripts with elevated m6A modification levels in their coding regions were bound by YTHDF2 (YT521-B homology m6A RNA-binding protein 2), leading to mRNA destabilization and decreased BNIP3 protein levels. These findings highlight the importance of FTO-dependent cardiac m6A methylation in regulating mitophagy and enhance our understanding of this critical interplay, which is essential for developing therapeutic strategies to protect cardiac mitochondrial function, alleviate cardiac dysfunction, and improve survival during sepsis.
Authors
- Xiawei Wei (ORCID: https://orcid.org/0000-0002-6513-6422)
- Rong Lucy He (ORCID: https://orcid.org/0000-0001-6116-8163)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-2316-0114)
- Rong Tang (ORCID: https://orcid.org/0000-0002-3087-2585)
- Hao Xu (ORCID: https://orcid.org/0000-0001-6542-5411)
- Minghe Jiang
- Ping‐Ping Qi
- Wenzhong Chen
- Shengkui Chen
- Minsheng Wu
- Bingquan Hu
- Yang Gao (ORCID: https://orcid.org/0000-0002-7910-3787)
Institutions
- Harbin Medical University (CN)
- Guangxi Medical University (CN)
- Guangxi University of Chinese Medicine (CN)
- Ruikang Affiliated Hospital of Guangxi Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Journal of Cellular Physiology
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1002/jcp.31448
- Citations
- 13
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.04